Apollo Intelligence, a Frazier Healthcare Portfolio Company, Acquires GlocalMind, Expanding its Global Reach and Operations in Healthcare and Life Science Market Insights

Extended access to HCPs further streamlines Apollo’s ability to deliver high-quality and timely insights and provides a technology-driven edge to teams developing and commercializing new therapies

WATERTOWN, Mass.--(BUSINESS WIRE)--Apollo Intelligence (Apollo), a leading provider of real-time data and insights to the healthcare and life science industries, has acquired GlocalMind, a global technology-driven healthcare market research services and panel company. Founded in 2010, with teams in the US, Europe, and India, GlocalMind provides access to healthcare professionals (HCPs) and key opinion leaders (KOLs) in Europe and Asia-Pacific (APAC) regions, featuring a research operating center of excellence in India. By adding GlocalMind’s real-time panel sourcing network and recruiting capabilities to its platform, Apollo further expands its panel access to global HCPs and KOLs to deliver multi-country healthcare market research with industry-leading speed-to-insights and high-quality data.

The acquisition of GlocalMind marks Apollo’s third move since 2019 to enhance its life science market insights offering, setting it apart in the industry. With a steadfast dedication to advancing healthcare and life sciences market research through technology and data, Apollo reaffirms its commitment to accelerating health innovation for a better life.

“Life science companies face unprecedented demands to bring new therapies to market faster than ever before. They need trusted insights partners with transformative solutions to do this,” said Daniel S. Fitzgerald, CEO and President of Apollo. “GlocalMind is a respected brand in our space and aligns with our commitment to tech-enabled innovation. As part of the Apollo family, GlocalMind supports our 'follow-the-sun' vision, optimizing time and efficiency for our clients around the globe.”

GlocalMind provides access to 1.5 million HCPs in more than 50 countries across 80+ physician specialties, as well as KOLs, payers, nurses, dentists, veterinarians, ophthalmologists, opticians, and pharmacists in Europe, APAC, the US, and Canada—key stakeholders who are sourced through directed research efforts using double opt-in, permission-based techniques. The company offers comprehensive programming, reporting, and project management support nearly around the clock, heavily supported via an India-based research operations team. Leveraging high-quality global panels, advanced systems/tools, customizable recruitment capabilities, and a deep understanding of local markets, GlocalMind effectively addresses qualitative and quantitative market research requirements for life science clients globally.

Sandeep Sankhla, GlocalMind’s founder, and Vrinda Deval, principal, will continue their leadership positions at GlocalMind following the acquisition, and will join the Apollo leadership team. The GlocalMind brand will be retained for the foreseeable future. GlocalMind’s India research operations team will provide an important component of Apollo’s global operations, affording more access and value-added services for all Apollo clients.

“GlocalMind and the Apollo brands were each first-movers in our respective domains, and our visions are aligned toward transforming the life science market research process,” said Sandeep Sankhla, founder of GlocalMind. “The GlocalMind team is thrilled to join Apollo and partner in pursuit of its bold vision, offering expanded and best in class services and solutions to new clients as part of the Apollo team. Together, we can accelerate our success and impact on the life sciences and healthcare industry.”

Apollo launched in 2019 with the acquisition of InCrowd, a pioneer of real-time, automated insights for the life sciences, followed in 2020 by the acquisition of Survey Healthcare Global, a global market leader in first-party healthcare data collection and custom survey solutions. In integrating GlocalMind’s unique culture of innovation and presence in key geographies, Apollo has now enlarged its portfolio to better serve the needs of the healthcare and life science community.

Apollo was assisted in this transaction by Goodwin Procter, LLP, as legal advisor to Apollo, and Alvarez & Marsal, acting as tax advisor.

About Apollo Intelligence, LLC

Apollo’s mission is to accelerate health innovation to improve life. In 2019, Apollo launched with the acquisition of InCrowd, a pioneer of real-time, automated insights for the life science industry. In 2020, Apollo strengthened its global reach by acquiring Survey Healthcare Global, a market leader in first-party healthcare data collection and custom survey solutions. In 2024, Apollo acquired GlocalMind, a global technology-driven healthcare market research services and panel company, expanding its reach in Europe and APAC while enhancing follow-the-sun efficiencies in life science market insights. Through these unique firms, Apollo provides access to two million healthcare stakeholders worldwide—physicians, KOLs, patients, caregivers, and allied healthcare professionals. Apollo’s 300+ employees support top global pharmaceutical and healthcare brands, market research agencies, and consultancies across 13 countries in the Americas, Europe, and Asia. Apollo is a portfolio company of Frazier Healthcare Partners. For more information about Apollo, please visit our website at www.apollointelligence.net.

Kate Maul
Marketing Director for Apollo Intelligence
kate.maul@apollointelligence.net
617-515-6819

Mary Kae Marinac
PR Representative for Apollo Intelligence
mk@mkmarinac.com
978-685-3136